Allergan has agreed to pay $600m as part of a settlement over the company's US marketing practices related to Botox
The US FDA has issued a safety warning to remind healthcare professionals of the increased mortality risk associated with antibacterial Tygacil
Eli Lilly has won a court victory that the company said will keep osteoporosis drug Evista protected from generic competition in the US until 2014
The European Commission has granted Archimedes Pharma marketing authorisation for PecFent, a nasal spray for breakthrough cancer pain in adults
The European Commission has approved AstraZeneca's Seroquel XR as an add-on treatment for major depressive disorder
Abbott and Roche lead the pack for rheumatologists in the latest medeConnect survey
Recent meetings between Government and key life sciences trade associations have been uniformly positive, boding well for the future
Strategies for small companies to defend themselves against big pharma stepping into specialised and orphan drug markets
Clause 19 can have real benefits when creating focused, educational conferences and events
The rise of the 'professional' patient signifies a new era for pharma marketing
